PTEN and prostate neoplasm: Together with our data this shows that down-regulation of PIK3R1 mRNA/p85α is more common in prostate tumours than mutation of the gene, and the effect of p85α on the PI3K pathway and tumour development is likely to be tissue and context-dependent and determined by the relative activities of p110α, p85α and PTEN.